Additionally, miR-155 stimulates the production of drug-resistance proteins associated with breast cancer, including Multidrug Resistance Protein 1 (MRP1), P-glycoprotein (P-gp), and Breast Cancer Resistance Protein (BCRP)83,84. This evidence concerns the gene ABCB1 and breast carcinoma.